Assays for therapeutic monitoring and pharmacokinetic investigations of aminoglycosides: Quality aspects

被引:9
|
作者
White, LO [1 ]
机构
[1] Southmead Gen Hosp, Bristol Ctr Antimicrobial Res & Evaluat, NEQAS Antibiot Assays, United Kingdom Natl External Qual Assessment Sche, Bristol BS10 5NB, Avon, England
关键词
aminoglycosides; immunoassays; pharmacokinetics;
D O I
10.1097/00007691-199810000-00003
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Clinical laboratory investigations used to aid antimicrobial chemotherapy of serious infection include routine sensitivity testing and, in the case of those drugs with a narrow therapeutic range, routine assays for therapeutic monitoring to assist with dosage individualization. Tests must be of a sufficiently high quality to be clinically useful. Laboratories ensure quality through standard operating procedures, internal quality control procedures, and participation in external quality assessment (EQA) programs. This article demonstrates how EQA returns to the United Kingdom National External Quality Assessment Scheme for Antibiotic Assays and the activity of the United Kingdom National Quality Assurance Advisory Panel showed marked improvement in the technical quality of assays as exemplified by gentamicin assays. The article also highlights additional quality concerns not subject to EQA.
引用
收藏
页码:464 / 468
页数:5
相关论文
共 50 条
  • [1] PHARMACOKINETIC INTERPRETATION OF NEPHROTOXIC EFFECT OF AMINOGLYCOSIDES - PHARMACOKINETIC ASPECTS OF NEPHROTOXICITY OF AMINOGLYCOSIDES
    FIRSOV, AA
    GAGAEVA, EV
    ANTIBIOTIKI I KHIMIOTERAPIYA, 1989, 34 (02) : 148 - 153
  • [2] REAPPRAISAL OF GUIDELINES FOR PHARMACOKINETIC MONITORING OF AMINOGLYCOSIDES
    YEE, GC
    EVANS, WE
    PHARMACOTHERAPY, 1981, 1 (01): : 55 - 75
  • [3] THERAPEUTIC MONITORING OF AMINOGLYCOSIDES IN THE NEONATE
    SPRUYT, LL
    KIRSTEN, G
    PARKIN, DP
    SOUTH AFRICAN JOURNAL OF SCIENCE, 1984, 80 (11) : 530 - 531
  • [4] Therapeutic drug monitoring: Analytical, pharmacokinetic and clinical aspects
    Marquet, P
    ACTA CLINICA BELGICA, 1999, : 2 - 12
  • [5] Therapeutic Drug Monitoring of Aminoglycosides in Neonates
    Daniël J. Touw
    Elsbeth M. Westerman
    Arwen J. Sprij
    Clinical Pharmacokinetics, 2009, 48 : 71 - 88
  • [6] Therapeutic Drug Monitoring of Aminoglycosides in Neonates
    Touw, Daniel J.
    Westerman, Elsbeth M.
    Sprij, Arwen J.
    CLINICAL PHARMACOKINETICS, 2009, 48 (02) : 71 - 88
  • [7] Therapeutic Drug Monitoring of Aminoglycosides in Neonates
    de Hoog, Matthijs
    van den Anker, John N.
    CLINICAL PHARMACOKINETICS, 2009, 48 (05) : 343 - 344
  • [8] Therapeutic Drug Monitoring of Aminoglycosides in Neonates
    Matthijs de Hoog
    John N. van den Anker
    Clinical Pharmacokinetics, 2009, 48 : 343 - 344
  • [9] Thinking about dried blood spots for pharmacokinetic assays and therapeutic drug monitoring
    Kissinger, Peter T.
    BIOANALYSIS, 2011, 3 (20) : 2263 - 2266
  • [10] Recent aspects of monitoring therapy with aminoglycosides and vancomycin
    Cheymol, G
    Poirier, JM
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 1998, 182 (02): : 285 - 298